Jefferies Financial Group Inc. Abbott Laboratories Call Options Transaction History

Jefferies Financial Group Inc.

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $785,694 - $877,032	7,800 New	7,800 $810,000
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $6.91 Million - $8.46 Million	-76,600 Reduced 72.26%	29,400 $3.24 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $114,636 - $137,544	-1,200 Reduced 1.12%	106,000 $10.3 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $8.34 Million - $9.3 Million	-82,800 Reduced 43.58%	107,200 $11.7 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $1.11 Million - $1.31 Million	11,500 Added 6.44%	190,000 $19.2 Million
Q4 2022 Sep 21, 2023	BUY	$95.06 - $111.52 $6.78 Million - $7.95 Million	71,300 Added 66.51%	178,500 $19.6 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $17 Million - $19.9 Million	178,500 New	178,500 $19.6 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.